Chimeric Antigen Receptor T Cells (CART) Therapy

· Innovative Cellular Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Chimeric Antigen Receptor T Cells (CART) Therapy, covering 2016-06-28 to 2016-06-28. Get the full timeline:

Most recent: Clinical Trial Update: Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies [NA]